Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
Clinical trial NCT02745119 · TERMINATED
Trial details
- NCT number
- NCT02745119
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-21
- Primary completion
- 2018-01-31
- Enrollment
- 994
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.